Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS)

NCT01439958 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Stopped Core study 12011.201 was terminated.

Conditions

Bronchiolitis Obliterans

Interventions

DRUG: Inhalation

Sponsor

Pari Pharma GmbH